https://www.selleckchem.com/TGF-beta.html
After the insufflation of sCT samples (40 µg-sCT/kg) in rats, sCT/SR-RP could enhance and prolong the hypocalcemic action of sCT possibly due to the sustained release and pulmonary absorption of sCT. From these observations, the strategic application of the FDD process could be efficacious to provide PLGA-based inhalable formulations of sCT, as well as other therapeutic peptides, to enhance their biopharmaceutical potentials.The irradiation effects of carbon and nitrogen medium energy ions (MEI) on charge transport, structural and optical prope
Like
Comment
Share
